Investigation Overview
An investigation on behalf of current long-term investors in shares of Immunomedics, Inc. (NASDAQ:IMMU) was announced over potential breaches of fiduciary duties by certain officers and directors at Immunomedics. The investigation by a law firm concerns whether certain Immunomedics directors breached their fiduciary duties and caused damage to the company and its shareholders. Morri...
You must register (for free) or login to view the entire investigation.